AMAG Pharma (AMAG) Reports Q3 Loss of 19c/Share; Updates Feraheme Revs Outlook
Tweet Send to a Friend
AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) reported Q3 EPS of ($0.19), $0.07 better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
